This report, for the first time in the literature, elucidated that OXT has a potential therapeutic effect on AD and acts by suppressing acetylcholinesterase activity, hippocampal Aβ deposition, and tau levels [58]. The gene discussed is MAPT; the disease is Alzheimer disease.